Summit Therapeutics
SMMT
#1969
Rank
S$13.13 B
Marketcap
S$17.64
Share price
-3.95%
Change (1 day)
-36.75%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: S$13.13 Billion

As of February 2026 Summit Therapeutics has a market cap of S$13.13 Billion. This makes Summit Therapeutics the world's 1969th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026S$13.13 B-24.25%
2025S$17.33 B-5.02%
2024S$18.25 B655.58%
2023S$2.41 B110.61%
2022S$1.14 B222.79%
2021S$0.35 B-30.52%
2020S$0.51 B252.96%
2019S$0.14 B460.6%
2018S$25.84 M-88.31%
2017S$0.22 B45.19%
2016S$0.15 B-23.6%
2015S$0.19 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Summit Therapeutics was reported to be:

S$13.67 Billion
by Nasdaq info icon info icon
S$13.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
S$2.27 B-82.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$0.28 B-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
S$0.32 B-97.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
S$7.85 B-40.20%๐Ÿ‡บ๐Ÿ‡ธ USA